Legend Biotech Corp Adjustments For Finance Income
Legend Biotech Corp (LEGN) reported Adjustments For Finance Income of $40.10 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForFinanceIncome · last filed 2026-03-10
- Legend Biotech Corp adjustments for finance income for the quarter ending 2025-12-31 was $7.95M, a 41.76% decline year-over-year.
- Legend Biotech Corp adjustments for finance income for the quarter ending 2025-09-30 was $9.66M, a 41.91% decline year-over-year.
- Legend Biotech Corp adjustments for finance income for the quarter ending 2025-06-30 was $10.43M, a 38.81% decline year-over-year.
- Legend Biotech Corp adjustments for finance income for the quarter ending 2025-03-31 was $12.06M, a 13.08% decline year-over-year.
| Period end | Adjustments For Finance Income 3 month | Adjustments For Finance Income 6 month | Adjustments For Finance Income 9 month | Adjustments For Finance Income 12 month | Adjustments For Finance Income 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $7.95M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $17.61M derived: sum of 2 quarters · filed 2026-03-10 | $28.04M derived: sum of 3 quarters · filed 2026-03-10 | $40.10M 20-F · filed 2026-03-10 | |
| 2025-09-30 | $9.66M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $20.09M derived: sum of 2 quarters · filed 2025-11-12 | $32.15M 6-K · filed 2025-11-12 | $45.80M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-06-30 | $10.43M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | $22.49M 6-K · filed 2025-08-11 | $36.14M derived: sum of 3 quarters · filed 2026-03-10 | $52.77M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-03-31 | $12.06M 6-K · filed 2025-05-13 | $25.71M derived: sum of 2 quarters · filed 2026-03-10 | $42.34M derived: sum of 3 quarters · filed 2026-03-10 | $59.39M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-12-31 | $13.65M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $30.28M derived: sum of 2 quarters · filed 2026-03-10 | $47.33M derived: sum of 3 quarters · filed 2026-03-10 | $61.20M 20-F · filed 2026-03-10 | $61.20M 20-F · filed 2025-03-11 |
| 2024-09-30 | $16.63M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $33.68M derived: sum of 2 quarters · filed 2025-11-12 | $47.55M 6-K · filed 2025-11-12 | $64.86M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-06-30 | $17.05M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | $30.92M 6-K · filed 2025-08-11 | $48.23M derived: sum of 3 quarters · filed 2026-03-10 | $66.65M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-03-31 | $13.87M 6-K · filed 2025-05-13 | $31.18M derived: sum of 2 quarters · filed 2026-03-10 | $49.60M derived: sum of 3 quarters · filed 2026-03-10 | $61.62M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2023-12-31 | $17.32M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $35.73M derived: sum of 2 quarters · filed 2026-03-10 | $47.74M derived: sum of 3 quarters · filed 2026-03-10 | $54.50M 20-F · filed 2026-03-10 | $54.49M 20-F · filed 2024-03-19 |
| 2023-09-30 | $18.42M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $30.43M derived: sum of 2 quarters · filed 2024-11-12 | $37.19M 6-K · filed 2024-11-12 | $42.07M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | $12.01M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | $18.77M 6-K · filed 2024-08-09 | $23.65M derived: sum of 3 quarters · filed 2025-03-11 | $25.16M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $6.75M 6-K · filed 2024-05-13 | $11.64M derived: sum of 2 quarters · filed 2025-03-11 | $13.15M derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2022-12-31 | $4.89M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $6.40M derived: sum of 2 quarters · filed 2025-03-11 | $8.18M 20-F · filed 2025-03-11 | ||
| 2022-09-30 | $1.51M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $3.29M 6-K · filed 2023-11-20 | |||
| 2022-06-30 | $1.79M 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | $971.00K 20-F · filed 2024-03-19 | ||||
| 2021-06-30 | $227.00K 6-K · filed 2021-08-23 | ||||
| 2020-12-31 | $2.93M 20-F · filed 2023-03-30 | ||||
| 2020-06-30 | $1.81M 6-K · filed 2021-08-23 | ||||
| 2019-12-31 | $4.58M 20-F/A · filed 2023-02-17 | ||||
| 2018-12-31 | $6.21M 20-F · filed 2021-04-02 |